GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vencanna Ventures Inc (XCNQ:VENI) » Definitions » Debt-to-Revenue

Vencanna Ventures (XCNQ:VENI) Debt-to-Revenue : 0.66 (As of Oct. 2024)


View and export this data going back to 1992. Start your Free Trial

What is Vencanna Ventures Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Vencanna Ventures's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Oct. 2024 was C$0.98 Mil. Vencanna Ventures's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Oct. 2024 was C$3.26 Mil. Vencanna Ventures's annualized Revenue for the quarter that ended in Oct. 2024 was C$6.38 Mil. Vencanna Ventures's annualized Debt-to-Revenue for the quarter that ended in Oct. 2024 was 0.66.


Vencanna Ventures Debt-to-Revenue Historical Data

The historical data trend for Vencanna Ventures's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vencanna Ventures Debt-to-Revenue Chart

Vencanna Ventures Annual Data
Trend Apr15 Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24
Debt-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only N/A N/A N/A N/A N/A

Vencanna Ventures Quarterly Data
Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only N/A N/A N/A 0.62 0.66

Competitive Comparison of Vencanna Ventures's Debt-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Vencanna Ventures's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vencanna Ventures's Debt-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Vencanna Ventures's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Vencanna Ventures's Debt-to-Revenue falls into.



Vencanna Ventures Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Vencanna Ventures's Debt-to-Revenue for the fiscal year that ended in Apr. 2024 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(0.695 + 3.016) / N/A
=N/A

Vencanna Ventures's annualized Debt-to-Revenue for the quarter that ended in Oct. 2024 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(0.984 + 3.258) / 6.384
=0.66

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Oct. 2024) Revenue data.


Vencanna Ventures Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Vencanna Ventures's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Vencanna Ventures Business Description

Traded in Other Exchanges
N/A
Address
622 5th Avenue S.W, Suite 200, Calgary, AB, CAN, T2P 0M6
Vencanna Ventures Inc aims to provide investors with a diversified, high-growth, cannabis investment strategy through strategic investments and acquisitions focused throughout the value chain (cultivation, processing, and distribution, including ancillary businesses.
Executives
Jonathan Robert Sharun Senior Officer
William Scott Mcgregor Director
David Gordon Mcgorman Senior Officer

Vencanna Ventures Headlines

No Headlines